GSK PLC
(NYSE:GSK)
$
34.08
-0.04 (-0.12%)
Market Cap: 69.61 Bil
Enterprise Value: 84.95 Bil
PE Ratio: 21.96
PB Ratio: 3.90
GF Score: 71/100 GlaxoSmithKline PLC at Cowen Healthcare Conference (Virtual) Transcript
Mar 01, 2021 / 05:20PM GMT
Release Date Price:
$34.68
(+0.36%)
Stephen Michael Scala
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst
Good afternoon, and welcome to this session featuring GlaxoSmithKline at Cowen's 41st Annual Healthcare Conference. We're very, very pleased to have with us Dr. Hal Barron, who is the Chief Scientific Officer and President of R&D at GlaxoSmithKline. Hal, thanks for taking away from your journey to transform GSK at this time to be with us. We're very, very appreciative of that.
Questions & Answers
Stephen Michael Scala
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst
Maybe we can start out by asking a high-level question on your thoughts on the progress being made within GSK R&D since you came on board. What would you say has gone very well? And what would you say has gone less well?
Hal V. Barron
GlaxoSmithKline plc - Chief Scientific Officer, President of R&D and Director
Well, thanks, Steve, for inviting me. It's a pleasure to be here. Yes. Let me start -- that's a
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot